Articles published by Lexeo Therapeutics
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
May 09, 2024
From Lexeo Therapeutics
Via GlobeNewswire
Tickers
LXEO
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing
March 13, 2024
From Lexeo Therapeutics
Via GlobeNewswire
Tickers
LXEO
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
March 11, 2024
From Lexeo Therapeutics
Via GlobeNewswire
Tickers
LXEO
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments
February 05, 2024
From Lexeo Therapeutics
Via GlobeNewswire
Tickers
LXEO
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
Lexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational Highlights
December 11, 2023
From LEXEO Therapeutics
Via GlobeNewswire
Tickers
LXEO
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
Lexeo Therapeutics Announces Pricing of Initial Public Offering
November 02, 2023
From LEXEO Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
![](https://ml.globenewswire.com/media/71b80760-e94a-403e-9011-e7a35b76c2fb/small/lexeo-logo-png.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.